Broadcom Inc. has announced a cash tender offer to purchase up to $2.5 billion of its outstanding senior notes across six series, with maturities ranging from 2030 to 2038. This move is part of the company's debt management strategy, as it currently holds $64.9 billion in total debt. The tender offers are set to expire on June 17, 2026, and holders whose notes are accepted will receive accrued interest.

Prudential has launched the "New Retirement Conversation" initiative, based on research with UCLA, to help financial advisors engage clients in more holistic retirement planning. This approach moves beyond purely financial metrics to understand clients' personal aspirations for retirement, redefining it as a transition focused on freedom and purpose rather than just an endpoint. Alongside this, Prudential is debuting the "UnReal Retirement" brand campaign to challenge traditional retirement clichés and promote personalized retirement visions.

Morgan Stanley Real Estate Investing (MSREI), through investment funds managed by Morgan Stanley Investment Management, announced the acquisition of a 300,000-square-foot mission-critical defense manufacturing facility in Taunton, MA. This acquisition aligns with MSREI's strategy of investing in institutional-quality net lease properties with investment-grade tenants in mission-critical facilities. The specialized nature of the facility and the tenant's operational investment are expected to ensure long-term occupancy.

MetLife has introduced the Non-Qualified Assignment Flex Agreement (NQA-FA), a deferred payment solution for non-physical injury claims, allowing flexible payment schedules beyond the one-year limit of traditional structures. This product is designed for various claims including employment litigation and contract disputes, and leverages a funding agreement instead of an annuity. MetLife shares (NYSE:MET) are considered undervalued, having gained 10.7% year-to-date.

Ashok Srivastava, Intuit's chief AI officer, dismisses the "SaaSpocalypse" narrative, attributing strong performance to disciplined AI adoption. He emphasizes the transformative impact of AI agents, noting a 40% increase in development speed and significant boosts in customer subscriptions and business efficiencies for products like QuickBooks and QuickBooks Capital. Srivastava also highlights Intuit's avoidance of "tokenmaxxing" due to their commitment to regulatory compliance and customer-centric AI applications.

Producer prices intensified in May, with the Producer Price Index climbing to 6.5% year-over-year, marking the highest reading since December 2022 and surpassing economist expectations. This surge was primarily driven by energy costs, particularly a significant increase in gasoline prices, raising concerns about inflation and the Federal Reserve's outlook. Despite the hot inflation data, Wall Street largely shrugged it off, with stock futures showing gains in early trading.

Oppenheimer has increased its price target for Tesla (NASDAQ:TSLA) due to anticipated higher demand for stationary storage and increased vehicle sales. The firm attributes this growth to Tesla's product evolution, cost reductions, and the supportive effect of elevated oil prices on global EV demand. Additionally, Oppenheimer noted that speculation regarding a potential merger with SPCX may provide some support for Tesla shares, recognizing CEO Elon Musk's strategy for diversified capital access with two public currencies.

Johnson & Johnson (JNJ) has expanded the U.S. availability of its Tecnis PureSee intraocular lens (IOL), an extended depth of focus (EDOF) lens for cataract surgery patients. The company highlights that 97% of patients report no bothersome visual disturbances, and it's the only EDOF IOL in the U.S. without a warning on loss of contrast sensitivity. This expansion coincides with Cataract Awareness Month, reinforcing J&J's commitment to innovation in surgical vision.

The first quarter of 2026 saw a shift in market sentiment, moving away from growth-oriented tech stocks due to geopolitical tensions and energy market disruptions, which negatively impacted the Guinness Global Innovators Fund. Adobe Inc. (ADBE) experienced soft performance as generative AI raised concerns about monetization and competitive intensity, despite the company's strong fundamentals and successful integration of AI-first products like Firefly. Investor uncertainty was exacerbated by maintained guidance and the CEO's retirement, prompting continued monitoring of ADBE's growth and quality credentials.

Takeda's AI-designed oral psoriasis drug, zasocitinib, significantly outperformed Bristol Myers Squibb’s Sotyktu in a Phase 3 study, achieving complete skin clearance in over 35% of patients at 16 weeks—more than 2.5 times the response rate of Sotyktu. These results position Takeda for an FDA filing for zasocitinib, which was acquired from Nimbus Therapeutics for $4 billion and targets the TYK2 protein to maintain IL-23 inhibition. The company plans to file drug applications with global health authorities starting this fiscal year, aiming to redefine the oral psoriasis market.